glp 1 constipation remedies on GLP-1 Medications: Causes & Step-by-Step Fix Managing GLP-1/GIP side effects with

Candeias et al., 2015)

10.3390/nu13082567 230

Use a gentle cleanser and a moisturizer that fits your skin type

Dosing Protocols in Research Most gene expression studies used GHK-Cu at concentrations equivalent to: Subcutaneous injection: 12 mg/day (common biohacking protocol) Topical application: 15% concentration creams/serums (skin-focused gene effects) In vitro concentrations: 10100 nM range in cell studies For subcutaneous use, peptide community protocols typically run: Dose: 12 mg/day Cycle: 3090 days on, 30 days off Injection site: Subcutaneous, rotating sites Common stack: GHK-Cu + BPC-157 (synergistic tissue repair), GHK-Cu + MOTS-C (longevity stack), GHK-Cu + Retatrutide (body recomposition with connective tissue support) Topical use is effective for skin-specific outcomes